
Hematology-Oncologyprecision medicineimmunotherapy
Precision Immunotherapy in Acute Myeloid Leukemia: Advancing Beyond Traditional Targets
By MedXY|Sep 28, 2026
Recent advances in identifying leukemia-restricted antigens enable subtype-specific immunotherapies in AML that selectively target malignant cells while sparing normal hematopoiesis, offering a promising new paradigm for precision treatment